Concepedia

Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic Stroke

Mar Castellanos, Rogelio Leira, Joaquı́n Serena, Miguel Blanco, Salvador Pedraza, José Castillo, Antoni Dávalos

Stroke · 2004 · 149 citations · 18 references

DOIFull text

Open access

Abstract

High plasma c-Fn levels are significantly associated with subsequent HT in stroke patients treated with tPA, so plasma c-Fn determinations might be useful in clinical practice to improve the risk/benefit ratio of thrombolytic treatment.

References

18

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Harold P. Adams, Birgitte H. Bendixen, L. Jaap Kappelle et al. · Stroke · 1993 · 12K citations · Full text

Tissue Plasminogen Activator for Acute Ischemic Stroke

The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group · New England Journal of Medicine · 1995 · 11.6K citations

, , +17

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Werner Hacke, Markku Kaste, Cesare Fieschi et al. · The Lancet · 1998 · 3.6K citations

, , +15

Hemorrhagic Transformation of Ischemic Brain Tissue

Christian Berger, Marco Fiorelli, Thorsten Steiner et al. · Stroke · 2001 · 548 citations · Full text

Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human Stroke

Joan Montaner, Carlos A. Molina, Jasone Monasterio et al. · Circulation · 2003 · 537 citations